Ces radiol. 2018, 72(2):71-75 | DOI: 10.55095/CesRadiol2018/012

Czech society of interventional radiology ČLS JEP guidelines for periprocedural medication in endovascular proceduresGuidelines

Marie Černá1, Miloslav Roček2, Jan H. Peregrin3, Martin Köcher1, Antonín Krajina4, Radek Pádr2, Josef Hořejš5, Filip Cihlář6
1 Radiologická klinika LF UP a FN, Olomouc
2 Klinika zobrazovacích metod II. LF UK a FN Motol, Praha
3 Pracoviště radiodiagnostiky a intervenční radiologie IKEM, Praha
4 Radiologická klinika LF UK a FN, Hradec Králové
5 Radiodiagnostická klinika 1. LF UK a VFN, Praha
6 Radiologická klinika FZS UJEP, Masarykova nemocnice o.z., Krajská zdravotní a.s., Ústí nad Labem

The aim of these guidelines is to provide new recommendations according to the latest knowledge.
The purpose of proper patient medication before endovascular procedure, during procedure and after endovascular procedure is to minimize the risk of periprocedural and postprocedural complications to the minimum.

Keywords: endovascular procedure, medication, guidelines

Accepted: April 26, 2018; Published: June 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černá M, Roček M, Peregrin JH, Köcher M, Krajina A, Pádr R, et al.. Czech society of interventional radiology ČLS JEP guidelines for periprocedural medication in endovascular procedures. Ces radiol. 2018;72(2):71-75. doi: 10.55095/CesRadiol2018/012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wiersema AM, Watts Ch, Durran AC, Reijnen MMPJ. The use of heparin during endovascular peripheral arterial interventions: A synopsis. Scientifica (Cairo) 2016; 2016: 1456298. doi: 10.1155/2016/1456298. Epub 2016 Apr 17. Go to original source... Go to PubMed...
    2. Vedantham s, Cesely TM, Sicard GA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004; 15(6): 565-575. Go to original source... Go to PubMed...
    3. Černá M, Roček M, Peregrin JH, et al. Doporučení České společnosti intervenční radiologie ČLS JEP pro přípravu pacienta před endovaskulárním výkonem. Ces Radiol 2017; 17(2): 101-108. Go to original source...
    4. Tsakiris DA, Tschöpl M, Jäger K, et al. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999; 142(1): 193-200. Go to original source... Go to PubMed...
    5. Tschöpl M, Tsakiris DA, Marbet GA, et al. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Throm Vasc Biol 1997; 17(11): 3208-3214. Go to original source... Go to PubMed...
    6. Jorgensen B, Jorgensen B, Meisner S, Holstein P, Tonnesen KH. Early rethrombosis in femoropopliteal occlusions treated with percutaneous transluminal angioplasty. European Journal of Vascular Surgery 1990; 4(2): 149-152. Go to original source... Go to PubMed...
    7. Haudenschild CC. Pathophysiology of reocclusion and restenosis. Fibrinolysis 1995; 9(Suppl 1): 44-47. Go to original source...
    8. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33(Suppl 1): S1-75. Go to original source... Go to PubMed...
    9. Weichert W, Meents H, Abt K, et al. Acetylsalicylic acid reocclusion prophylaxis after angioplasty (ARPA study). A randomized double-blind trial of two different dosages of ASA in patients with peripheral occlusive arterial disease. Vasa 1994; 23(1): 57-65.
    10. Minar E, Ahmadi A, Koppensteiner R, et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 1995; 91(8): 2167-2173. Go to original source... Go to PubMed...
    11. Ranke C, Creutzig A, Luska G, et al. Controlled trial of high-versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease. Clinical Investigator 1994; 72(9): 673-680. Go to original source... Go to PubMed...
    12. Dotter CT. Two decades of transluminal angioplasty. An overview. J Mal Vasc 1982; 7(Suppl 4): 357-361.
    13. Sapoval MR, Chatellier G, Long AL, et al. Self-expandable stents for the treatment of iliac artery obstructive lesions: long-term success and prognostic factors. AJR 1996; 166(5): 1173-1179. Go to original source... Go to PubMed...
    14. Carnevale FC, De Blas M, Merino S, Egana JM, Galdas JG. Percutaneous endovascular treatment of chronic iliac artery occlusion. Cardiovasc Intervent Radiol 2004; 27(5): 447-452. Go to original source... Go to PubMed...
    15. Alterburg A, Haage P. Antiplatelet and anticoagulant drugs in interventional radiology. CardioVascular and Interventional Radiology 2011; 35(1): 30-42. Go to original source... Go to PubMed...
    16. Brott TG, Halperin JL, Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Neurointerventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol 2011; 57(8): 1002-1044. doi:10.1016/j.jacc.2010.11.005. Epub 2011 Feb 1. Go to original source... Go to PubMed...
    17. Ries T, Buhk JH, Kucinski T, et al. Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006; 37(7): 1816-1821. Go to original source... Go to PubMed...
    18. Yamada NK, Cross DT 3rd, Pilgram TK, et al. Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007; 28(9): 1778-1782. Go to original source... Go to PubMed...
    19. Ullery BW, Tran K, Itoga N, et al. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease. J Vasc Surg 2015; 61(6): 1479-1488. Go to original source... Go to PubMed...
    20. Saratzis A, Saratzis N, Melas N, Kiskinis D. Pharmacotherapy Before and After Endovascular Repair of Abdominal Aortic Aneurysms. Current Vascular Pharmacology 2008; 6(4): 240-249. Go to original source... Go to PubMed...
    21. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 2006; 27(6): 647-654. Go to original source... Go to PubMed...
    22. Michos ED, Ardehali R, Blumenthal RS, Lange RA, Ardehali H. Aspirin and clopidogrel resistence. Mayo Clin Proc 2006; 81(4): 518-526. Go to original source... Go to PubMed...
    23. Ray ChE, Prochazka CA. The Need for Anticoagulation Following Inferior Vena Cava Filter Placement: Systematic Review. Cardiovasc Intervent Radiol 2008; 21(3): 316-324. Go to original source... Go to PubMed...
    24. Yazu T, Fujioka H, Nakamura M, et al. Long-term results of inferior vena cava filters. Experiences in a Japanese population. Intern Med 2000; 39(9): 707-714. Go to original source... Go to PubMed...
    25. Dovrish Z, Hadary R, Blickstein D, Shilo L, Ellis M. Retrospective analysis of the use of inferior vena cava filters in routine hospital practice. Postgrad Med J 2006; 82(964): 150-153. Go to original source... Go to PubMed...
    26. Schleich JM, Morla O, Laurent M, Langella B, Chaperon J, Almange C. Long-term follow-up of percutaneous vena cava filters: a prospective study in 100 consecutive patients. Eur J Vasc Endovasc Surg 2001; 21(5): 450-457. Go to original source... Go to PubMed...
    27. Greenfield L, Proctor M. Twenty-year clinical experience with the Greenfield filter. Cardiovasc Surg 1995; 3(2): 199-205. Go to original source... Go to PubMed...
    28. Hicks ME, Middleton WD, Picus D, Darcy MD, Kleinhoffer MA. Prevalence of local venous thrombosis after transfemoral placement of a Bird's Nest vena caval filter. J Vasc Interv Radiol 1990; 1(1): 63-68. Go to original source... Go to PubMed...
    29. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Beven EG, Bay JW. Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors: anticoagulants or inferior vena cava filter? Arch Intern Med 1987; 147(12): 2177-2179. Go to original source...
    30. Walsh DB, Downing S, Nauta R, Gomes MN. Metastatic cancer a relative contraindication to vena cava filter placement. Cancer 1987; 59(1): 161-163. Go to original source...
    31. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ. Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141(2 Suppl): 7S-47S. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content